Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism ANO1 stimulants(anoctamin 1 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Enterprise Therapeutics Ltd.Startup |
Active Organization- |
Inactive Organization Enterprise Therapeutics Ltd.Startup |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystic Fibrosis | Phase 1 | GB | Enterprise Therapeutics Ltd.Startup | 13 Aug 2020 |